Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Thursday, March 28, 2024 · 699,447,424 Articles · 3+ Million Readers

Myrtol® 300 Named a Finalist in the 6th Annual SupplySide West CPG Editor’s Choice Awards

Respiratory Health Supplement Chosen as One of Five Finalists in the Specialty Supplement Category of Prestigious Industry Award

Los Angeles, CA, Sept. 14, 2017 (GLOBE NEWSWIRE) -- Natural dietary supplement, Myrtol® 300, was selected as a Specialty Supplement finalist for the SupplySide West CPG Editor’s Choice Awards.

Myrtol(R) 300
Myrtol(R) 300 is a finalist in in the 6th Annual SupplySide West CPG Editor's Choice Awards.


Myrtol® 300 is a dietary supplement that uses a proprietary blend of essential oils to help soothe coughs and support a healthy respiratory system. Other finalists in the Specialty Supplement category include Essential Source, Radical Blends Inc., Twinlab Consolidation Corporation, and Vermont Village Sipping.

The SupplySide editoral team chose five consumer packaged goods (CPG) products in each of the 27 award categories for demonstrated achievements in innovation and market impact. Each product submitted was required to be a new product launched between July 2016 and Summer 2017.

“We have seen many people have a positive experience using Myrtol 300 and we’re very excited to now see a top-tier industry publication recognize the benefits of the product,” said Thomas Höppner, Executive Director, Marketing and Sales at Pohl-Boskamp, creators of Myrtol® 300. “We know the product is very effective and we’re excited to see this finalist status help boost awareness of the benefits of Myrtol 300.”

A recent survey conducted on behalf of Myrtol 300 in January 2017 found that on average, Americans have cold and/or flu symptoms at least five times in a typical year. The survey revealed Americans’ preferences for dietary supplements that help soothe coughs and support their respiratory system without making them feel drowsy.

Myrtol® 300 was created by Pohl-Boskamp, a German-based pharmaceutical business, which has sold approximately 250 million capsules worldwide. The product was originally launched and sold as Gelomyrtol in the European market, and has been used for over 40 years by millions of people in 23 countries around the world.

Award winners will be announced at SupplySide West 2017 during the SupplySide CPG Editor’s Choice Awards Presentations, set for September 27 and 28 at the Mandalay Bay Resort in Las Vegas, Nevada.

To learn more about Myrtol® 300, visit www.TryMyrtol300.com.  

About Myrtol® 300

Myrtol® 300 helps soothe coughs due to throat irritation while also helping to support a healthy respiratory system. Recognized as the “German pill” with a funny name, Myrtol® 300 was initially launched in the European market and has been used for more than 40 years by millions of people in 23 different countries. The dietary supplement provides lung and sinus support and helps to clear and maintain a healthy respiratory tract. Now available in the U.S., Myrtol® 300 can be purchased without a prescription.

About Pohl-Boskamp

Pohl-Boskamp is a privately-owned business active in the international pharmaceutical market for 175 years with commercialized products in more than 45 countries, and which has now emerged into the U.S. nutraceutical industry. Through close collaboration with its partners abroad, Pohl-Boskamp focuses on developing and marketing products that positively impact patients' quality of life. It operates in numerous healthcare sectors including pneumology, urology, parasitology, cardiovascular diseases and dermatology. Learn more at Pohl-Boskamp.com.  

MEDIA CONTACT:
                    Brittany Galvan
                    (310) 405-0346
                    brittany@marketingmavenpr.com  
                    

Primary Logo

Powered by EIN News


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release